Novo Nordisk today presented new data from the OASIS 4 phase 3 trial that explored a variety of patients and hypotheses, ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...

Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much ...

A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss effects.

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

Using the weight loss jab Wegovy may help reduce a person’s risk of heart attack or stroke, regardless of how much weight ...

A novel machine learning gene risk biomarker test successfully predicted patient response to semaglutide treatment after ...

Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, ...

The cardiovascular benefits of weight loss drug semaglutide (Ozempic, Wegovy) occur regardless of how much weight a person loses or their starting body weight, new analysis suggests.1 Study authors ...

Ozempic, a diabetes drug, is gaining traction for weight loss, fuelled by celebrity buzz like Karan Johar's transformation.